Summary

• 100% technical buy signals.
• 12 new highs and up 18.34% in the last month.
• 15.27% gain in the last year.

The Barchart Chart of the Day belongs to an under-followed clinical-stage biopharmaceutical company Kiniksa Pharmaceuticals (KNSA). I found the sotck by sorting Barchart's Top Stocks to Own list first by the most frequent number of new highs in the last month, then used the Flipchart feature to review the charts for consistent price appreciation. Since the Trendspotter signaled a buy on 11/21 the stock gained 118.12%.

Kiniksa Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with a significant unmet medical need. Kiniksa Pharmaceuticals Ltd. is based in Massachusetts, United States.

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can, therefore, change during the day as the market fluctuates. The indicator numbers shown below, therefore, may not match what you see live on the Barchart.com website when you read this report.

Barchart technical indicators:

• 100% technical buy signals
• 20.10+ Weighted Alpha
• 15.27% gain in the last year
• TrendSpotter buy signal
• Above its 20, 50 and 100 day moving averages
• 12 new highs and up 18.34% in the last month
• Relative Strength Index 66.94%
• Technical support level at 19.28
• Recently traded at 19.57 with a 50 day moving average of 15.84

Fundamental factors:

• Market Cap $1.08 billion
• Although 4 Wall Street analysts issued strong buy recommendations they did not have a consensus about revenue and earnings projections
• 886 investors are monitoring the stock on Seeking Alpha